Search - tctmd.com

Displaying 61 - 80 of 124

Sort: Relevancy | Date

Presentation TCT 2022

TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison

Presenter: Tijn Jansen

September 19, 2022

Presentation TCT 2022

TCT 302: MRR by Continuous Thermodilution is not Influenced by the Ray Flow Catheter Effect on Coronary Resistance

Presenter: Alejandro Gutierrez-Barrios

September 19, 2022

Presentation TCT 2022

TCT 301: The role of the collateral circulation in stable coronary artery disease: a placebo-controlled study in patients with stable angina.

Presenter: Christopher Rajkumar

September 19, 2022

Presentation TCT 2022

TCT 300: The impact of coronary microvascular dysfunction on fractional flow reserve and resting full-cycle ratio discordance in the assessment of borderline coronary lesions

Presenter: Piotr Szolc

September 18, 2022

Presentation TCT 2022

TCT 298: Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death

Presenter: David Hong

September 18, 2022

Presentation TCT 2022

TCT 297: Prevalence of Coronary Microvascular Disease in Patients with Non-Obstructive Coronary Artery Disease

Presenter: Carlos Collet

September 18, 2022

Presentation TCT 2022

TCT 296: Post-Spastic Flow Recovery Time to Document Vasospasm Induced Ischemia during Acetylcholine Provocation Testing.

Presenter: Janneke Woudstra

September 18, 2022

Presentation TCT 2022

TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial

Presenter: SHIGETAKA KAGEYAMA

September 18, 2022

News Daily News

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Yael L. Maxwell

June 03, 2022

News Conference News ACC 2022

In ANOCA, Diltiazem Fails to Improve Vasomotor Function: EDIT-CMD

Caitlin E. Cox

April 02, 2022

News Daily News

ACC Releases Guidance on CV Issues With COVID-19

Todd Neale

March 16, 2022

News Daily News

Before and After PCI, Women Have Poorer Health Status Than Men

L.A. McKeown

January 28, 2022

News Daily News

Vasospasm Linked to Higher Atherosclerotic Risk in Patients With ANOCA

Yael L. Maxwell

January 27, 2022

News Daily News

Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim

Caitlin E. Cox

November 24, 2021

News Daily News

Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death

L.A. McKeown

November 11, 2021

Presentation TCT 2021

Case-Based Presentation 5: INOCA – How to Diagnose and Treat Coronary Microvascular Dysfunction (CMD)

Presenter: Colin Berry

November 06, 2021

CTO PCI Ups Survival Amid High Ischemia Burden in Single-Center Registry

News Daily News

CTO PCI Ups Survival Amid High Levels of Ischemia in Single-Center Series

Yael L. Maxwell

July 05, 2021

News Daily News

Differentiating Type 1 and Type 2 MI Still ‘Both Art and Science’

Todd Neale

April 23, 2021

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Todd Neale

February 08, 2021

Presentation SCAD 2021

Can microvascular coronary dysfunction co-exist with SCAD?

Presenter: Tara Sedlak

January 30, 2021

Advertisement

TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison

TCT 302: MRR by Continuous Thermodilution is not Influenced by the Ray Flow Catheter Effect on Coronary Resistance

TCT 301: The role of the collateral circulation in stable coronary artery disease: a placebo-controlled study in patients with stable angina.

TCT 300: The impact of coronary microvascular dysfunction on fractional flow reserve and resting full-cycle ratio discordance in the assessment of borderline coronary lesions

TCT 298: Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death

TCT 297: Prevalence of Coronary Microvascular Disease in Patients with Non-Obstructive Coronary Artery Disease

TCT 296: Post-Spastic Flow Recovery Time to Document Vasospasm Induced Ischemia during Acetylcholine Provocation Testing.

TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

In ANOCA, Diltiazem Fails to Improve Vasomotor Function: EDIT-CMD

ACC Releases Guidance on CV Issues With COVID-19

Before and After PCI, Women Have Poorer Health Status Than Men

Vasospasm Linked to Higher Atherosclerotic Risk in Patients With ANOCA

Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim

Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death

Case-Based Presentation 5: INOCA – How to Diagnose and Treat Coronary Microvascular Dysfunction (CMD)

CTO PCI Ups Survival Amid High Levels of Ischemia in Single-Center Series

Differentiating Type 1 and Type 2 MI Still ‘Both Art and Science’

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Can microvascular coronary dysfunction co-exist with SCAD?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content